Management of Persistent Pediatric Obstructive Sleep Apnea After Adenotonsillectomy

Saturday, September 28, 2024

9:30 AM – 10:30 AM EDT

Location: MBCC, 238-239

CME/MOC Credit: 1

Disclosure(s):

Derek J. Lam, MD, MPH:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Erin M. Kirkham, MD, MPH:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

PROGRAM DESCRIPTION: The first line treatment for obstructive sleep apnea (OSA) in children is
adenotonsillectomy (AT). Persistent OSA occurs in 30% of otherwise healthy children after AT. In children with obesity, craniofacial, genetic or neuromuscular disorders, persistent OSA after AT is as high as 70%. Thus, otolaryngologists are increasingly managing this challenging patient population.
Despite this, there are no guidelines regarding the optimal management of children with persistent OSA after AT. The role of observation, drug induced sleep endoscopy (DISE), cine MRI, allergy evaluation, CPAP, and turbinate, palatal and tongue base surgeries including upper airway stimulation will be discussed.

Learning Objectives:

Examine the challenges and solutions for managing children with persistent OSA after AT.
Assess the modalities for evaluation and treatment of children with persistent OSA.
Propose an algorithm for the management of children with persistent OSA using case-based learning.

Lead Presenter(s)

Derek J. Lam, MD, MPH

Associate Professor
Oregon Health & Science University
Portland, OR, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Co-Presenter(s)

EK

Erin M. Kirkham, MD, MPH

Assistant Professor - Otolaryngology Head & Neck Surgery
University of Michigan
ANN ARBOR, MI, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.